from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2267c/-

LFCtreatmentdescriptionclass of inhibitor

-0.791

Amikacinug/mL Amikacintranslation

-0.851

Cap5-10ug/mL Capreomycintranslation

-1.426

Rox10-50 ug/mL Roxithromycintranslation

-0.604

SM2-5 ug/mL Streptomycintranslation

-0.596

Tet5-10 ug/mL Tetracyclinetranslation

0.029

Rif0.2-5ug/mL Rifampicintranscription

-0.212

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.519

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.692

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.219

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.078

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.627

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.471

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.426

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.509

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.241

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.575

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.542

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.792

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.245

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.817

KCN5-20 ug/mL Potassium cyaniderespiration

-1.039

NaN30.2-2 mM Sodium aziderespiration

-0.642

Nigericin50 uM Nigericinrespiration

0.194

TRC10-150 ug/mL Triclosanrespiration

-0.107

TRZ10-25 ug/mL Thioridazinerespiration

-0.381

Valinomycin0.5-10 uM Valinomycinrespiration

-2.017

ZnSO42 mM ZnSO4respiration

-0.549

menadione6-10 ug/mL Menadionerespiration

-0.130

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.439

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.009

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.699

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.462

NRP_1Non-replicating persistence stage 1dosRassociated

-0.696

Amp0.2mg/mL AmpicillincellWall

0.094

Cephalexin20-100 ug/mL CephalexincellWall

-0.744

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.076

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.489

EMB10-20 ug/mL EthambutolcellWall

-0.677

Eta12-40 ug/mL EthionamidecellWall

-0.792

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.246

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.404

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.310

BZA0.12 mg/mL BenzamidearomaticAmides

0.348

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.694

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.713

H2O24 mM hydrogen peroxideDNAdamaging

-0.728

Levo10 ug/mL LevofloxacinDNAdamaging

1.105

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.287

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.488

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.948

UVUV-irradiationDNAdamaging

0.355

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.122

Antimycin12.5-50 ug/mL Antimycin A?

-0.263

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.033

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.135

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.308

PA8240.2-2 ug/mL PA-824?

0.192

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.480

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.122

Verapamil50 uM Verapamil?

0.413

mercaptoethanol2 mM 2-Mercaptoethanol?

0.385

methoxatin10-20 ug/mL Methoxatin?